GDRX

Peers: OPRX DOCS PHR HIMS TDOC LFMD HQY AMWL CVS CI

| Held by: VTI DFSV VXF VB DFAT VBR SCHA DFAS VHT DFAC

Index	-
Market Cap	1.22B
Enterprise Value	1.46B
Income	16.25M
Sales	785.23M
Book/sh	1.90
Cash/sh	0.87
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	697
IPO	Sep 23, 2020

P/E	75.80
Forward P/E	10.16
PEG	1.74
P/S	1.55
P/B	1.88
P/C	4.11
P/FCF	6.18
EV/EBITDA	7.99
EV/Sales	1.86
Quick Ratio	1.38
Current Ratio	1.38
Debt/Eq	0.83
LT Debt/Eq	0.82
Option/Short	Yes / Yes

EPS (ttm)	0.05
EPS next Y	0.35
EPS next Q	0.08
EPS this Y	-13.33%
EPS next Y	15.79%
EPS next 5Y	5.83%
EPS past 3/5Y	- -
Sales past 3/5Y	1.30% 7.67%
EPS Y/Y TTM	-48.77%
Sales Y/Y TTM	-1.83%
EPS Q/Q	-31.94%
Sales Q/Q	-1.31%
Earnings	Aug 05 AMC
EPS/Sales Surpr.	0.38% 3.72%

Insider Own	74.18%
Insider Trans	-1.08%
Inst Own	15.70%
Inst Trans	0.20%
ROA	0.89%
ROE	2.52%
ROIC	1.38%
Gross Margin	79.54%
Oper. Margin	12.00%
Profit Margin	2.07%
SMA20	5.94%
SMA50	3.57%
SMA200	27.71%
Trades

Shs Outstand	106.16M
Shs Float	88.07M
Short Float	4.72%
Short Ratio	3.22
Short Interest	4.16M
52W High	4.05 -11.85%
52W Low	1.77 101.69%
Volatility	4.20% 3.50%
ATR (14)	0.12
RSI (14)	59.08
Beta	1.69
Rel Volume	0.00
Avg Volume	1.29M
Volume	0

Perf Week	5.62%
Perf Month	3.78%
Perf Quarter	24.39%
Perf Half Y	50.63%
Perf YTD	31.73%
Perf Year	-8.23%
Perf 3Y	-34.97%
Perf 5Y	-92.40%
Perf 10Y	-
Recom	2.73
Target Price	3.95
Prev Close	3.57
Price	3.57
Change %	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-27-26	Downgrade	JP Morgan	Overweight → Neutral
Jan-22-26	Downgrade	Jefferies	Buy → Hold	$2.75
Dec-09-25	Initiated	Barclays	Underweight	$3
Aug-11-25	Downgrade	Raymond James	Strong Buy → Outperform
Dec-04-24	Initiated	Mizuho	Neutral	$5
Aug-09-24	Upgrade	Raymond James	Outperform → Strong Buy	$10
May-23-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$8 → $10
May-16-24	Upgrade	Raymond James	Mkt Perform → Outperform	$10
Apr-10-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$9
Mar-25-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$7.50 → $10
Mar-01-24	Upgrade	JP Morgan	Neutral → Overweight	$7 → $10
Feb-26-24	Initiated	Leerink Partners	Outperform	$8
Jan-02-24	Downgrade	BofA Securities	Buy → Underperform	$8 → $4.50
Aug-10-23	Upgrade	DA Davidson	Neutral → Buy	$9.50
Jul-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$6.50 → $12
Dec-01-22	Initiated	Citigroup	Buy	$7
Nov-04-22	Upgrade	JP Morgan	Underweight → Neutral	$10 → $8
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold	$6.50
Aug-12-22	Initiated	DA Davidson	Neutral	$8

Show Previous Ratings

Sep-03-26 09:00AM	From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household (Business Wire)
Aug-06-26 08:30AM	GoodRx Holdings, Inc. Q2 2026 Earnings Call Summary (Moby) +13.76%
Jul-09-26 04:05PM	GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call (Business Wire)
May-27-26 09:00AM	GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs (Business Wire)
May-18-26 06:09PM	Trump Announces Discount Drug Pricing Expansion With Mark Cuban (Bloomberg)
08:30AM	Loading…
May-07-26 08:30AM	GoodRx Holdings, Inc. Q1 2026 Earnings Call Summary (Moby) +10.51%
May-06-26 04:05PM	GoodRx Reports First Quarter 2026 Results (Business Wire)
May-01-26 08:10AM	GoodRx Expands Offerings to Now Include Ozempic Pill for Type 2 Diabetes Patients (Business Wire) +8.05%
Apr-17-26 04:05PM	GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call (Business Wire)
Apr-15-26 09:00AM	GoodRx Now Offers Access to Wegovy HD at $399 Per Month Self-Pay Price (Business Wire)
Apr-09-26 07:30AM	GoodRx Expands Access to Eli Lilly and Company's New Oral GLP-1, Foundayo, and Zepbound KwikPen with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide (Business Wire)
Mar-11-26 09:00AM	GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications (Business Wire) -6.25%
Mar-06-26 09:00AM	GoodRx to Expand Employer-Sponsored Access to Zepbound KwikPen (Business Wire)
Feb-27-26 12:39PM	Hims & Hers Expands Digital Health and Global Platform Strategy (Zacks) -6.03%
Feb-26-26 08:05PM	GoodRx Holdings, Inc. Q4 2025 Earnings Call Summary (Moby) -18.78%
04:13PM	Loading…
04:13PM	GoodRx Holdings Inc (GDRX) Q4 2025 Earnings Call Highlights: PharmaDirect Surge and Strategic ... (GuruFocus.com)
03:48PM	GoodRx Q4 Earnings Call Highlights (MarketBeat)
09:30AM	Here's What Key Metrics Tell Us About GoodRx (GDRX) Q4 Earnings (Zacks)
Feb-25-26 05:34PM	GoodRx's (NASDAQ:GDRX) Q4 CY2025 Sales Top Estimates But Stock Drops 11.8% (StockStory)
04:05PM	GoodRx Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
Feb-24-26 09:00AM	GoodRx Expands Into Employer Market With Launch of "GoodRx Employer Direct" (Business Wire)
08:50AM	Sotera Health Company (SHC) Q4 Earnings and Revenues Beat Estimates (Zacks)
Feb-23-26 10:21PM	GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect (StockStory) -8.10%
Feb-17-26 11:07PM	GoodRx (GDRX): Buy, Sell, or Hold Post Q3 Earnings? (StockStory) +7.21%
Feb-09-26 05:25PM	Medpace (MEDP) Beats Q4 Earnings and Revenue Estimates (Zacks) -9.43% +5.43%
Feb-06-26 11:16AM	Headwinds in GoodRx's (GDRX) Drug Prescription Business Draw Cautious View from Jefferies (Insider Monkey) +6.55%
10:28AM	Hims & Hers Strengthens Platform-Led Digital Healthcare Model (Zacks)
Feb-05-26 07:44PM	GoodRx Powers Pricing for Leading Brand Medications on TrumpRx (Business Wire)
Feb-02-26 09:00AM	GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale (Business Wire)
Jan-28-26 04:05PM	GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call (Business Wire)
10:31PM	Loading…
Jan-25-26 10:31PM	Q3 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks (StockStory)
Jan-13-26 08:00AM	Surescripts and GoodRx Partner to Advance Patient Price Transparency (Business Wire)
Jan-12-26 10:00AM	Hims & Hers Expands Platform-Led Access to Provider-Directed Care (Zacks)
Jan-10-26 02:21PM	BofA Maintains Underperform Rating on GoodRx (GDRX) While Trimming PT to $2.60 (Insider Monkey)
Jan-08-26 09:00AM	GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies (Business Wire)
Jan-05-26 11:54AM	Novo Nordisk's Wegovy Pill Hits Pharmacies. It's the Latest Move in the Weight-Loss Showdown. (Barrons.com)
08:05AM	GoodRx Now Offers Novo Nordisks Cash Price for the Launch of the Wegovy Pill (Business Wire)
Dec-28-25 12:46PM	Morgan Stanley Favors GoodRx (GDRX) and Healthcare Tech Over Managed Care for 2026 Citing Strong Market-Beating Potential (Insider Monkey)
Dec-19-25 07:36AM	Tempus AI Approaching Profitability Despite GAAP Losses (Zacks)
Dec-16-25 04:05PM	GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
12:11PM	Hims & Hers Scales Technology-Driven Care as Profitability Evolves (Zacks)
Dec-09-25 02:15PM	Why GoodRx (GDRX) Stock Is Trading Lower Today (StockStory)
11:25AM	Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell? (Zacks)
12:20AM	What Does Wall Street Think About GoodRx Holdings (GDRX)? (Insider Monkey)
Dec-05-25 07:59AM	Wegovy's prices are going down, but they are 'wildly different' (MarketWatch)
Nov-28-25 12:38PM	HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside? (Zacks)
Nov-21-25 10:54AM	Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model (Zacks)
Nov-17-25 08:35AM	GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic and Wegovy (Business Wire)
Nov-11-25 12:33AM	5 Revealing Analyst Questions From GoodRx's Q3 Earnings Call (StockStory)
Nov-09-25 11:45PM	3 Value Stocks We Find Risky (StockStory)
Nov-07-25 09:34PM	Goldman Sachs Raises GoodRx (GDRX) Price Target, Keeps Neutral Rating (Insider Monkey)
Nov-06-25 08:00AM	GoodRx Holdings Inc (GDRX) Q3 2025 Earnings Call Highlights: Strong Manufacturer Solutions ... (GuruFocus.com) -5.11%
Nov-05-25 05:05PM	GDRX Q3 Deep Dive: Manufacturer Solutions Growth Offsets Flat Prescription Volumes (StockStory)
Nov-04-25 07:30PM	Here's What Key Metrics Tell Us About GoodRx (GDRX) Q3 Earnings (Zacks)
06:35PM	GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings Estimates (Zacks)
04:41PM	GoodRx's (NASDAQ:GDRX) Q3 Sales Top Estimates (StockStory)
04:05PM	GoodRx Reports Third Quarter 2025 Results (Business Wire)
08:03AM	GoodRx Holdings Inc (GDRX) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-03-25 07:44AM	GoodRx Holdings Inc (GDRX) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Nov-02-25 10:05PM	GoodRx (GDRX) Q3 Earnings Report Preview: What To Look For (StockStory)
Oct-31-25 01:58PM	Hims & Hers Scales AI-Driven Personalized Health and Wellness (Zacks)
Oct-26-25 06:43AM	GoodRx Launches New 'GoodRx for Hair Loss' Subscription Service for Men (Insider Monkey)
Oct-21-25 12:02AM	GoodRx (GDRX): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Oct-15-25 09:00AM	GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment (Business Wire)
Oct-10-25 08:33AM	GoodRx Hopes to Play a Role in TrumpRx, CEO Says. The Stock Rises. (Barrons.com) -7.97%
Oct-09-25 02:10PM	GoodRx Is in Talks to Join TrumpRx, Report Says. The Stock Is Rising. (Barrons.com) +5.69%
01:53PM	Hims & Hers Expands Personalized Care Access Via Telehealth Platform (Zacks)
Oct-08-25 04:05PM	GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call (Business Wire)
Oct-07-25 01:45PM	Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60% (Zacks)
Oct-06-25 11:31PM	Q2 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks (StockStory)
09:15AM	GoodRx Expands Affordable Access to Repatha with Nearly 60% Savings (Business Wire)
Oct-03-25 01:06PM	Why GoodRx (GDRX) Stock Is Up Today (StockStory)
Oct-01-25 05:07PM	GoodRx stock soars after CEO hints at potential TrumpRx partnership (Investing.com) +18.91% -10.64%
09:00AM	GoodRx Launches Brand Medication Savings Program at National Retail Pharmacy (Business Wire)
Sep-30-25 02:49PM	Wall Street Has a Mixed Opinion on GoodRx Holdings (GDRX) (Insider Monkey)
Sep-16-25 10:23AM	Hims & Hers Expands AI and Technology Focus to Advance Digital Care (Zacks)
Sep-15-25 08:17AM	GoodRx Holdings Launches New Campaign, 'The Savings Wrangler' (Insider Monkey)
Sep-05-25 02:35PM	Why GoodRx (GDRX) Shares Are Sliding Today (StockStory) -6.54%
06:00AM	Why weight-loss 'wonder drugs' aren't 'wonder stocks' yet (Yahoo Finance)
Sep-02-25 09:00AM	GoodRx Saddles Up With The Savings Wrangler, a Bold New Brand Campaign to Tame the Wild West of Prescription Pricing (Business Wire)
Aug-31-25 12:16AM	Leerink Partners Reiterates a Buy Rating on GoodRx Holdings (GDRX) With a $6 PT (Insider Monkey)
Aug-27-25 12:32PM	Why GoodRx (GDRX) Stock Is Up Today (StockStory)
Aug-26-25 02:56PM	GoodRx (GDRX) Stock Is Up, What You Need To Know (StockStory)
Aug-18-25 04:25PM	GoodRx, Meta, CVS: Trending Tickers (Yahoo Finance Video) +37.27% -8.79%
02:40PM	Why GoodRx (GDRX) Stock Is Trading Up Today (StockStory)
01:00PM	Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisks breakup with Hims (FastCompany)
12:05PM	GoodRx CEO discusses GLP-1 deal with Novo Nordisk: What to know (Yahoo Finance Video)
11:39AM	Novo Nordisk Adds Ozempic to Direct-to-Consumer Offerings, at $499 Per Month. Why GoodRx Stock Spikes. (Barrons.com)
11:36AM	Ozempic And Wegovy Now Available Through GoodRx At Reduced Self-Pay Price, Stock Skyrockets (Benzinga)
10:31AM	Novo Cuts Price of Ozempic in Half for Cash Buyers (Bloomberg)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
09:53AM	GoodRx Stock Spikes 35% on Novo Nordisk Collaboration. They're Offering Ozempic for $499 a Month. (Barrons.com)
09:05AM	GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic and Wegovy for $499-Per-Month (Business Wire)
09:00AM	GoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month (Yahoo Finance)
09:00AM	GoodRx begins selling Novo Nordisk GLP-1s for cash price (Yahoo Finance)
Aug-17-25 06:32PM	GoodRx (GDRX) Lifts Guidance as Pharma Partnerships Drive Double-Digit Growth (Insider Monkey)
Aug-13-25 01:35AM	The Top 5 Analyst Questions From GoodRx's Q2 Earnings Call (StockStory)
Aug-11-25 09:45AM	GDRX Q2 Deep Dive: Headwinds from Rite Aid and PBM Disruptions Offset Pharma Solutions Growth (StockStory)
Aug-06-25 07:30PM	Compared to Estimates, GoodRx (GDRX) Q2 Earnings: A Look at Key Metrics (Zacks) -20.05%
06:45PM	GoodRx Holdings, Inc. (GDRX) Q2 Earnings and Revenues Lag Estimates (Zacks)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FRANCISCO PARTNERS IV, L.P.	10% Owner	Aug 26 '26	Sale	3.50	1,296,177	4,541,917	0	Aug 26 09:20 PM
FRANCISCO PARTNERS IV, L.P.	10% Owner	Aug 24 '26	Sale	3.46	143,594	497,122	706,649	Aug 26 09:20 PM
FRANCISCO PARTNERS IV, L.P.	10% Owner	Aug 25 '26	Sale	3.44	127,273	438,443	643,466	Aug 26 09:20 PM
FRANCISCO PARTNERS IV, L.P.	10% Owner	Aug 19 '26	Sale	3.53	471,975	1,666,025	1,127,436	Aug 21 09:38 PM
FRANCISCO PARTNERS IV, L.P.	10% Owner	Aug 20 '26	Sale	3.52	447,259	1,574,575	913,592	Aug 21 09:38 PM
FRANCISCO PARTNERS IV, L.P.	10% Owner	Aug 21 '26	Sale	3.50	274,717	960,630	777,213	Aug 21 09:38 PM
Francisco Partners GP IV, L.P.	10% Owner	Aug 19 '26	Proposed Sale	3.72	2,760,995	10,270,901		Aug 19 02:21 PM
IAN THORNTON CLARK	Director	May 13 '26	Proposed Sale	2.59	43,100	111,620		May 13 05:00 PM
REY-GIRAUD AGNES	Director	Mar 12 '26	Option Exercise	0.47	192,185	90,327	277,633	Mar 13 07:22 PM

GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. It offers consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. The company was founded by Trevor Bezdek and Douglas Joseph Hirsch in September 2011 and is headquartered in Santa Monica, CA.

PresidentMs. Wendy Barnes

Co-founder & DirectorMr. Douglas Joseph Hirsch

Chief Strategy & Operations OfficerMr. Justin Fengler

Chief Accounting Officer & Principal AccountingMr. Thomas Chan

Chief Technology OfficerMr. Nitin Shingate

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GoodRx Holdings Inc

Upgrade your Finviz experience